Effect of antihypertensive drugs on breast cancer risk in female hypertensive patients: Evidence from observational studies

Effect of antihypertensive drugs on breast cancer risk in female hypertensive patients: Evidence from observational studies

This systematic review aimed to evaluate the association between antihypertensive drugs and risk of breast cancer, and provide therapeutic implications for female hypertensive patients with different physical appearance. The prevalence of hypertension and female breast cancer is on the rise with age...

Full description

Bibliographic Details
Main Authors:	Yang Zhao, Qiongying Wang, Xu Zhao, Huitao Meng, Jing Yu
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2018-01-01
Series:	Clinical and Experimental Hypertension
Subjects:	angiotensin-converting enzyme inhibitor angiotensin receptor blocker antihypertensive drugs beta-blockers breast cancer
Online Access:	http://dx.doi.org/10.1080/10641963.2017.1288736

Similar Items

Prescription pattern and effectiveness of antihypertensive drugs in patients with aortic dissection who underwent surgery
by: Kung-Ming Laio, et al.
Published: (2023-11-01)

The complete reversal effect following angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and beta-blockers after the primary diagnosis of dilated cardiomyopathy
by: Tao Liu, et al.
Published: (2023-01-01)

Concomitant use of renin-angiotensin-aldosterone system inhibitors prevent trastuzumab-induced cardiotoxicity in HER2+ breast cancer patients: an institutional retrospective study
by: Melissa Y. Y. Moey, et al.
Published: (2019-07-01)

Resistance to antihypertensive drugs targeting Renin-Angiotensin-Aldosterone-System in cancer patients: a case series
by: Mishita Goel, et al.
Published: (2020-08-01)

Influence of Antihypertensive Treatment on RAAS Peptides in Newly Diagnosed Hypertensive Patients
by: Annina S. Vischer, et al.
Published: (2021-03-01)

Management of Hypertension with Female Sexual Dysfunction
by: Qing Zhong, et al.
Published: (2022-05-01)

Effect of antihypertensive treatment on the long-term outcome of patients discharged after acute ischemic stroke
by: Konstantinos Tziomalos, et al.
Published: (2017-04-01)

Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network
by: Steven M. Smith, et al.
Published: (2023-01-01)

Effect of angiotensin-converting enzyme inhibitors versus that of angiotensin receptor blockers on survival in patients undergoing hemodialysis: a nationwide observational cohort study
by: Seok Hui Kang, et al.
Published: (2024-12-01)

Neurohumoral Activation in Heart Failure
by: Antonis A. Manolis, et al.
Published: (2023-10-01)

Angiotensin II Receptor Blockers Reduce Tau/Aß42 Ratio: A Cerebrospinal Fluid Biomarkers’ Case-Control Study
by: Gemma García-Lluch, et al.
Published: (2023-03-01)

Is there a difference between an angiotensin-converting enzyme inhibitor and an angiotensin-specific receptor blocker for the treatment of hypertension?
by: James A. Ker
Published: (2015-05-01)

Hypertension, medications, and risk of severe COVID‐19: A Massachusetts community‐based observational study
by: Ann Z. Bauer, et al.
Published: (2021-01-01)

Association of Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With the Risk of Hospitalization and Death in Hypertensive Patients With COVID‐19
by: Rohan Khera, et al.
Published: (2021-07-01)

Bradykinin-Mediated Angioedema Induced by Commonly Used Cardiovascular Drugs
by: Janina Hahn, et al.
Published: (2023-09-01)

A study of prognosis and outcome of COVID-19-infected hypertensive patients on angiotensin-converting enzyme inhibitors/angiotensin receptor blockers
by: M S Bharath, et al.
Published: (2024-01-01)

PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL
by: N. A. Morina, et al.
Published: (2017-11-01)

The problem of determining the efficiency of treatmentin the era of evidence-based medicine: international and domestic experience
by: S R Gilyarevsky
Published: (2014-06-01)

Clinical outcomes of COVID-19 following the use of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers among patients with hypertension in Korea: a nationwide study
by: Ju Hwan Kim, et al.
Published: (2020-12-01)

Angiotensin‐Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID‐19 Infection Among 824 650 Patients With Hypertension From a US Integrated Healthcare System
by: Jaejin An, et al.
Published: (2021-02-01)

COVID-19 morbidity and mortality associated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers use among 14,129 patients with hypertension from a US integrated healthcare system
by: Jaejin An, et al.
Published: (2021-06-01)

The Pharmacogenomics of Anti-Hypertensive Therapy
by: Sandosh Padmanabhan, et al.
Published: (2010-06-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT
by: S. Yu. Martsevich
Published: (2015-09-01)

Antiproteinuric effects of antihypertensive agents in non-diabetic hypertensive population
by: Jovic Zorica, et al.
Published: (2008-09-01)

Renin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort study
by: Jenny I. Shen, et al.
Published: (2017-06-01)

Influence of angiotensin converting enzyme inhibitors/angiotensin receptor blockers on the risk of all‐cause mortality and other clinical outcomes in patients with confirmed COVID‐19: A systemic review and meta‐analysis
by: Na Jia, et al.
Published: (2021-09-01)

Drug-induced visceral angioedema
by: Prashanth M. Thalanayar, et al.
Published: (2014-09-01)

Clinical outcome of renin-angiotensin-aldosterone system blockers in treatment of hypertensive patients with COVID-19: a systematic review and meta-analysis
by: Andrea Laurentius, et al.
Published: (2021-02-01)

TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS
by: L. N. Malay, et al.
Published: (2016-01-01)

Effectiveness of angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers on total and cardiovascular mortality and morbidity in primary prevention: A nationwide study based on French Health Insurance Data (SNDS)
by: Emmanuel Oger, et al.
Published: (2022-04-01)

Skin Reactions with Losartan and Enalapril in Cardiac Patients
by: Fariba Iraji, et al.
Published: (2012-03-01)

Comparison of Angiotensin‐Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Management Strategies Before Cardiac Surgery: A Pilot Randomized Controlled Registry Trial
by: Sean van Diepen, et al.
Published: (2018-10-01)

Angiotensin-converting enzyme inhibitors or sartans in patients at high risk for cardiovascular events: a wrong question or an undesirable answer
by: S R Gilyarevsky, et al.
Published: (2013-03-01)

Associations Between the Use of Renin–Angiotensin System Inhibitors and the Risks of Severe COVID-19 and Mortality in COVID-19 Patients With Hypertension: A Meta-Analysis of Observational Studies
by: Xiao-Ce Dai, et al.
Published: (2021-04-01)

Effectiveness and Safety of Fixed-dose Combination of Perindopril/Amlodipine/Indapamide, and Telmisartan/Amlodipine/Chlorthalidone in Grade 2 Hypertensive Patients at High Cardiovascular Risk: A Real-world Observational Study
by: Shambo Samrat Samajdar, et al.
Published: (2023-01-01)

Drugs acting on the renin–angiotensin–aldosterone system (RAAS) and deaths of COVID-19 patients: a systematic review and meta-analysis of observational studies
by: Ruchika Sharma, et al.
Published: (2022-09-01)

Immunomodulatory Activity of the Most Commonly Used Antihypertensive Drugs—Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
by: Paweł Bryniarski, et al.
Published: (2022-02-01)

ACE inhibitor angioedema: characterization and treatment versus non-ACE angioedema in acute hospitalized patients
by: David S. Weisman, et al.
Published: (2020-01-01)

Study Hypothesis: Age, Gender, Presence of Diabetes Mellitus or Hypertension, and Anti-Hypertensive Drugs Are Independent Risk Factors for COVID-19 Mortality
by: Faruk Karandere, et al.
Published: (2023-01-01)

Oral drugs for hypertensive urgencies: systematic review and meta-analysis
by: Luciana Mendes Souza, et al.